carbenoxolone sodium has been researched along with ovalbumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, B; Kumar, S; Ram, A; Singh, SK; Singh, VP | 1 |
| Cheng, Q; He, F; Li, N; Shang, Y | 1 |
2 other study(ies) available for carbenoxolone sodium and ovalbumin
| Article | Year |
|---|---|
Inhaled carbenoxolone prevents allergic airway inflammation and airway hyperreactivity in a mouse model of asthma.
Topics: Administration, Inhalation; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Carbenoxolone; Disease Models, Animal; Immunoglobulin E; Lung; Male; Mice; Mice, Inbred BALB C; Nebulizers and Vaporizers; Ovalbumin | 2009 |
Carbenoxolone Ameliorates Allergic Airway Inflammation through NF-κB/NLRP3 Pathway in Mice.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Carbenoxolone; Caspase 1; Disease Models, Animal; Inflammasomes; Inflammation; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; NF-KappaB Inhibitor alpha; NLR Family, Pyrin Domain-Containing 3 Protein; Ovalbumin | 2022 |